Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Janux Therapeutics (JANX) Gains from Investment Securities (2021 - 2025)

Janux Therapeutics (JANX) has disclosed Gains from Investment Securities for 5 consecutive years, with $7.0 million as the latest value for Q4 2025.

  • Quarterly Gains from Investment Securities rose 1755.2% to $7.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $16.7 million through Dec 2025, up 73.1% year-over-year, with the annual reading at $9.5 million for FY2025, 7.6% up from the prior year.
  • Gains from Investment Securities for Q4 2025 was $7.0 million at Janux Therapeutics, down from $10.0 million in the prior quarter.
  • The five-year high for Gains from Investment Securities was $10.0 million in Q3 2025, with the low at -$924000.0 in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $3.8 million, with a median of $1.8 million recorded in 2022.
  • The sharpest move saw Gains from Investment Securities surged 8789.91% in 2023, then crashed 312.47% in 2025.
  • Over 5 years, Gains from Investment Securities stood at -$526000.0 in 2021, then surged by 241.06% to $742000.0 in 2022, then crashed by 224.53% to -$924000.0 in 2023, then surged by 140.58% to $375000.0 in 2024, then surged by 1755.2% to $7.0 million in 2025.
  • According to Business Quant data, Gains from Investment Securities over the past three periods came in at $7.0 million, $10.0 million, and $1.6 million for Q4 2025, Q3 2025, and Q2 2025 respectively.